When a laboratory SOP comes up for review, most attention lands on assay steps, equipment calibration and waste handling. The peptide inventory quietly sits in the background — often as a spreadsheet inherited from a previous post, an unlabelled box in the −20 °C freezer, or a folder of certificates nobody has opened in a year. Tightening that record is a small project with outsized value: it makes batch traceability routine, keeps storage conditions defensible at audit, and ensures the SOP describes materials that are genuinely in the building. The approach below is deliberately modest — a small, well-documented set of research-use-only materials rather than a deep catalogue — and is written for laboratory researchers and materials managers working in vitro.
Define the Inventory Scope Before You Amend the SOP
A SOP update is the right moment to stop treating the peptide shelf as an accumulating collection. Begin with an assay table that lists, for each compound in use: the in-vitro protocol it supports, the working concentration required, the diluent and volume used, the vial size held, and the number of experimental runs expected before the labelled expiry date. Anything without a named protocol behind it should be removed from the controlled list rather than carried forward by habit.
Match each vial to a defined in-vitro purpose
In practice, this usually produces a small inventory — perhaps one or two vials per compound per review cycle, sized to the work actually scheduled. The current Research Sciences catalogue illustrates the sort of research-use-only items that typically appear on such a list: Tesamorelin 5mg, TB-500 5mg, Ipamorelin 5mg, CJC-1295 (No DAC) 5mg, GHK-Cu 50mg, MT-1 10mg and BPC-157 10mg, alongside 10ml Mixing Water (also listed as Bacteriostatic Water 10ml) and a storage container. Prices and availability change, so the live product page — not a printed SOP appendix — should remain the reference point for what is currently supplied.
Keep the catalogue small and individually sourced
One useful constraint is that Research Sciences does not supply blended peptides, such as Ipamorelin combined with CJC-1295. Its published guidance recommends buying peptides individually and combining them only within a controlled experimental design. That suits SOP practice well, because each vial then carries its own label, its own certificate and its own storage record, rather than a shared identity that is difficult to trace back to a single batch.
Every item discussed here is supplied strictly for controlled laboratory and analytical research. These materials are not for human or veterinary use, not for consumption or administration, and not medicines, medical devices or food supplements under UK law. The purchaser remains responsible for lawful use, safe handling, storage, disposal and compliance with relevant UK regulations, including COSHH and laboratory safety standards.
Build the Documentation Trail: CoAs, Labels and ITR References
Documentation should be captured at the point of receipt, not reconstructed later. A practical receipt log records the date received, the product name and SKU, the vial label reference, the quantity, the storage location, the CoA file reference and the initials of the person who booked it in. That single line then becomes the anchor for everything the SOP asks you to demonstrate at audit.
Read the certificate that travels with the batch
Research Sciences states that a Certificate of Analysis accompanies every product, with HPLC data covering purity and identity, and that compounds are independently tested and subject to final verification and quality checks in the UK before release. The homepage lists “CoAs Janoshik Analytical Reports”, and the About page describes full-spectrum testing covering purity, identity, heavy metals and endotoxin evaluation. Treat these as the shop’s published wording, not as figures to copy into a SOP: the exact purity is stated on the batch CoA and should be reconfirmed from that document before the vial is released into a protocol. Purity figures quoted on the site, such as “≥99% Verified Purity”, should likewise be rechecked on the live page and against the CoA for the specific batch.
Quote the label reference in every record
Vial labels use a reference format that combines the SKU code and expiry date, for example BPC10-03/27, linking back to the corresponding CoA. Quoting that reference when contacting the supplier about documentation keeps correspondence short and unambiguous. Two further points belong in the SOP notes: restocked products may carry the same Internal Test Reference as earlier stock, and an ITR links to associated sample testing reports without confirming that separate deliveries share a production lot or have each been independently tested; and vial cap colour is not an indicator of identity, analytical quality or manufacturing origin. Where teams need to review current listings and their documentation, they can Buy peptides uk from the live catalogue and then check each product page and batch CoA before ordering.
One excipient detail is also worth recording: the shop’s FAQs state that all peptides contain trace amounts of mannitol, included to aid stability during lyophilisation, solubility and protection in storage. That belongs in the inventory notes so that any analytical interference or weighing discrepancy is not misread as a handling error. All materials remain research-use-only and not for human or veterinary use.
Write Storage, Handling and Review Rules Into the SOP Text
Storage clauses should be explicit rather than inherited. Lyophilised peptides are stored at −20 °C or below, sealed with desiccant and protected from moisture, heat and light, with repeated freeze–thaw cycles avoided. Receipt should include a temperature-aware check, and the storage location recorded in the log should match the physical position in the freezer — drawer, rack and box — so that stock checks do not depend on memory.
Keep reconstitution inside the in-vitro workflow
Handling language should stay firmly within laboratory practice. Vials are allowed to reach room temperature before opening, work takes place in a clean environment, and only the amount required for the experiment is removed. Where an assay calls for a working solution, the SOP should specify the diluent volume and target concentration for that in-vitro application, allow peptide and solvent to reach ambient temperature before reconstitution, and note that reconstitution solutions are supplied separately. The site’s free reconstitution calculator is described as a laboratory research tool covering mg, mcg, mL, U-100 and U-50 scales, with optional IU conversions when a conversion factor is known; it must not be used for human or veterinary dosing. Reconstituted material is less stable and should be held at 2–8 °C for short-term laboratory use only.
Record dispatch information, then review on a fixed cycle
Published fulfilment terms state that orders are dispatched the next working day via Royal Mail Tracked 24, which usually delivers the following working day according to Royal Mail estimates, with a tracking number issued after dispatch. These are estimates rather than guarantees, so the receipt log should note the tracking reference and the actual arrival date. Finally, build a review cadence into the SOP itself: a quarterly reconciliation of log against freezer, a defined change-control step for adding or withdrawing a compound, training sign-off for anyone permitted to open a vial, and disposal routed through the laboratory’s own COSHH and waste procedures. When the SOP text and the inventory record are updated together, the documentation stops being an afterthought and becomes part of the method.
Busan environmental lawyer now in Montréal advocating river cleanup tech. Jae-Min breaks down micro-plastic filters, Québécois sugar-shack customs, and deep-work playlist science. He practices cello in metro tunnels for natural reverb.